Advocacy intelligence hub — real-time data for patient organizations
Chigenovo Co., Ltd — NA
Gang Chen — PHASE4
Biocad — PHASE1
Chigenovo Co., Ltd — PHASE3
Shanghai Vitalgen BioPharma Co., Ltd. — PHASE3
NGGT (Suzhou) Biotechnology Co., Ltd. — PHASE1, PHASE2
Shanghai Vitalgen BioPharma Co., Ltd. — PHASE1
Chigenovo Co., Ltd — PHASE1, PHASE2
Xiamen Ophthalmology Center Affiliated to Xiamen University — EARLY_PHASE1
Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
FINANCIAL LANDSCAPE SUMMARY
Total programs
Wenbin Wei
Beijing Tongren Hospital
Jinlu Zhang, MD
Chigenovo Co., Ltd
Xiaorong Li, MD, DOM
Tianjin Medical University Eye Hospital
📍 ALBUQUERQUE, NM
James F Hejtmancik, M.D.
National Eye Institute (NEI)
Pamela Becker
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium